ClinicalTrials.gg
Not yet recruitingNCT07664501D-STORMUpdated Jun 25, 2026

The Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population (D-STORM)

An interventional study of D-STORM Resistance Training Programme and usual care in Type 2 Diabetes Mellitus (T2DM), Sarcopenia and Insulin Resistance, sponsored by Universiti Teknologi Mara. Not yet recruiting at 1 site in Malaysia. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Universiti Teknologi Mara · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia — 19 open to participants now, 19 under way, 6 of them phase 3. Diabetes Mellitus, Type 2 · Malaysia.

Planned enrollment
126th of 149
56 · median 370
Started
2027
the only one that year
No phase
39 of 170
9 open now
Primary completion
2027-09
later than 9 of 18 live
Registered
163rd of 170
by date

Among the 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia, this one is the 126th largest by planned enrollment of the 149 interventional ones that give a count, is the only one that started in 2027, is one of 39 with no phase, reaches primary completion later than 9 of the 18 other live ones, and was the 163rd registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

19 of the 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Malaysia have not opened yet or have stopped. Only those recruiting at a site in Malaysia →

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia, or all of them as a file.
02

Study summary

Type 2 diabetes is associated with progressive loss of muscle mass, which worsens blood sugar control and increases the risk of heart disease and disability. Resistance training (weight training) has been shown to build muscle and improve blood sugar levels, but most existing programmes use high intensities that are difficult for older or inactive people with diabetes to sustain.

This study tests a new resistance training programme called D-STORM (Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population), which uses a lower, more manageable training load designed to be safe, tolerable, and effective for adults with Type 2 diabetes who are not on insulin.

Participants will be randomly assigned to either twice-weekly D-STORM training plus their usual diabetes care, or usual care alone, for 12 weeks. The main outcome measured is change in HbA1c (a blood test reflecting average blood sugar over 3 months). Body composition, walking capacity, blood pressure, heart rate, and quality of life will also be measured.

Read the detailed description

The D-STORM trial is a 2-arm parallel randomised controlled trial conducted at Hospital Sultan Al-Abdullah (HASA), Puncak Alam, Selangor, Malaysia. Adults aged 18 to 65 years with Type 2 diabetes mellitus (HbA1c 6.5% to 13.0%) who are not on insulin therapy will be recruited and randomly allocated 1:1 to the D-STORM intervention arm or the usual care arm.

The D-STORM programme consists of 6 compound resistance exercises performed twice weekly on non-consecutive days for 12 weeks, at 60-80% of one-repetition maximum (1RM), 2 working sets per exercise, using the double progression model with sets terminated at 1-3 repetitions in reserve (RIR).

The primary outcome is between-group difference in HbA1c (%) from baseline to 12 weeks, with a minimum clinically important difference of 1.0% absolute reduction. Secondary outcomes include body composition (bioelectrical impedance analysis; InBody 270), functional exercise capacity (Incremental Shuttle Walk Test), blood pressure, resting heart rate, and health-related quality of life (SF-36). Sample size: 124 participants (62 per arm), accounting for 10% dropout.

03

Conditions studied

  • Type 2 Diabetes Mellitus (T2DM)
  • Sarcopenia
  • Insulin Resistance

Keywords

  • Type 2 diabetes mellitus
  • Resistance training
  • Muscular hypertrophy
  • Glycaemic control
  • HbA1c
  • Cardiometabolic outcomes
  • Randomised controlled trial
  • Minimal effective dose
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 to 65 years
  • Confirmed diagnosis of Type 2 Diabetes Mellitus
  • between 6.5% and 13.0%
  • Not currently on insulin therapy
  • Has a primary care provider

Exclusion criteria

Exclusion Criteria:

  • Age below 18 or above 65 years
  • Blood pressure 160/100 mmHg or higher at screening
  • below 6.5% or above 13.0%
  • Currently on insulin therapy
  • Pregnant or planning to become pregnant within the next 6 months
  • Serious medical conditions that would prevent safe participation in an exercise programme
  • Any physical or functional limitation that would prevent participation in resistance training
  • Underlying conditions that would not allow safe participation in the exercise intervention
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    D-STORM Training plus Usual Care

    Participants perform the D-STORM resistance training programme twice weekly on non-consecutive days for 12 weeks, comprising 6 compound exercises at 60-80% 1RM, 2 working sets per exercise, terminated at 1-3 repetitions in reserve, using the double progression model. Participants also continue their usual diabetes care throughout.

    Behavioral: D-STORM Resistance Training Programme

  • Active comparator
    Usual Care

    Participants receive standard diabetes care in accordance with the Malaysian Clinical Practice Guidelines for Type 2 Diabetes Management (6th Edition), including general physical activity recommendations of at least 150 minutes of moderate-intensity aerobic activity per week. No structured or supervised exercise is provided.

    Other: usual care

Interventions

  • BehavioralD-STORM Resistance Training Programme

    Twice-weekly progressive resistance training comprising 6 compound exercises (upper body pull, upper body push, lower body push, lower body pull) at 60-80% 1RM, 2 working sets per exercise per session (minimum 4 sets per muscle group per week), 8-12 repetitions per set, terminated at 1-3 repetitions in reserve. Load is progressively increased using the double progression model. Total intervention duration is 12 weeks.

  • Otherusual care

    Participants receive standard diabetes care in accordance with the Malaysian Clinical Practice Guidelines for Type 2 Diabetes Management (6th Edition), including general physical activity recommendations of at least 150 minutes of moderate-intensity aerobic activity per week distributed over at least 3 days, with resistance exercise on a minimum of 2 non-consecutive days per week. No structured, supervised, or progressive training is provided.

06

What researchers measure

Primary outcomes

  1. Glycated Haemoglobin (HbA1c)

    Between-group difference in HbA1c (%) from baseline to 12 weeks. The minimum clinically important difference is defined as a reduction of ≥1.0% absolute HbA1c. Measured by standardised laboratory assay at baseline (Visit 1) and post-intervention (Visit 7).

    Time frame: Baseline to 12 weeks

Secondary outcomes

  1. Body Composition

    Segmental body composition including skeletal muscle mass, fat mass, fat-free mass, and body fat percentage measured by bioelectrical impedance analysis (InBody 270) under standardised conditions.

    Time frame: Baseline to 12 weeks

  2. Functional Exercise Capacity

    Assessed using the Incremental Shuttle Walk Test (ISWT), measuring the maximum distance walked under a progressively increasing pace protocol.

    Time frame: Baseline to 12 weeks

  3. Blood Pressure

    Systolic and diastolic blood pressure (mmHg) measured at Visits 1, 3, 5, 7, and 9.

    Time frame: Baseline to 12 weeks

  4. Resting Heart Rate

    Resting heart rate (bpm) measured at Visits 1, 3, 5, 7, and 9.

    Time frame: Baseline to 12 weeks

  5. Health-Related Quality of Life

    Assessed using the SF-36 questionnaire at baseline and post-intervention (12 weeks).

    Time frame: Baseline to 12 weeks

  6. Exercise Self-Efficacy

    Self-reported exercise self-efficacy measured by validated questionnaire at baseline and post-intervention (12 weeks).

    Time frame: Baseline to 12 weeks

07

Study locations

1 site
  • Hospital Sultan Al-Abdullah (HASA)
    Kuala Selangor, Selangor 42300, Malaysia
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in the published article will be made available after de-identification, including text, tables, figures, and appendices.

Supporting information: Study protocol

Time frame: Beginning 6 months after publication, for a period of 5 years.

Access criteria: Data will be shared with researchers who provide a methodologically sound proposal. Proposals should be directed to the corresponding author. To gain access, data requestors will need to sign a data access agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Sep 2027, 8 months later.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 8 months is below that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 17, 2026
First posted
Jun 24, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Sep 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07664501
Lead sponsor
Universiti Teknologi Mara
Responsible party
Muhamad Faiz Bin Alias (Principal Investigator, Universiti Teknologi Mara) — Principal investigator
First posted
Jun 24, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 25, 2026

Study contacts

Muhamad Faiz Alias, BPT, MSc (sport science)
Contact
faiz.fisio@gmail.com
+60355442912

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion